Author:
MacDonald Douglas A.,Martin Joel,Muthusamy Kathir K.,Luo Jiann-Kae,Pyles Erica,Rafique Ashique,Huang Tammy,Potocky Terra,Liu Yang,Cao Jingtai,Bono Françoise,Delesque Nathalie,Savi Pierre,Francis John,Amirkhosravi Ali,Meyer Todd,Romano Carmelo,Glinka Meredith,Yancopoulos George D.,Stahl Neil,Wiegand Stanley J.,Papadopoulos Nicholas
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Clinical Biochemistry,Physiology
Reference42 articles.
1. Gerber HP, Hillan KJ, Ryan AM, Kowalski J, Keller GA, Rangell L, Wright BD, Radtke F, Aguet M, Ferrara N (1999) VEGF is required for growth and survival in neonatal mice. Development 126(6):1149–1159
2. Grothey A, Galanis E (2009) Targeting angiogenesis: progress with anti-VEGF treatment with large molecules. Nat Rev Clin Oncol 6(9):507–518. doi: 10.1038/nrclinonc.2009.110
3. Hauser S, Weich HA (1993) A heparin-binding form of placenta growth factor (PlGF-2) is expressed in human umbilical vein endothelial cells and in placenta. Growth Factors 9(4):259–268
4. Bressler SB (2009) Introduction: understanding the role of angiogenesis and antiangiogenic agents in age-related macular degeneration. Ophthalmology 116(10 Suppl):S1–S7. doi: 10.1016/j.ophtha.2009.06.045
5. Bressler NM (2004) Age-related macular degeneration is the leading cause of blindness. JAMA 291(15):1900–1901
Cited by
32 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献